Friday 12 December, 2008

Valganciclovir (Valcyte): Setback to Cipla in trademark infringement case

Innovator Hoffman-La Roche won a partial victory in its legal battle against India’s Cipla Ltd over anti-infection drug valganciclovir, with the Bombay high court ruling in favour of the Swiss company in a trademark infringement case. Mumbai high Court has stopped Cipla from using Valcept trade name as it’s similar to trade name Valcyte used by innovator Roche.
However, the court adjourned a patent infringement case for eight weeks because Roche’s patent on the drug itself has been set aside by the Madras high court till 31 January. A Tamilnaidu based NGO has filed pre-grant opposition against Roche’s patent on valganciclovir.
Source: Livemint news Here

No comments:

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker